Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Παρόμοια τεκμήρια

• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  ανά: Chen, W, κ.ά.
  Έκδοση: (2018)
• Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
  ανά: Xue, L, κ.ά.
  Έκδοση: (2018)
• Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
  ανά: Hardman, C, κ.ά.
  Έκδοση: (2019)
• Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
  ανά: Xue, L, κ.ά.
  Έκδοση: (2019)
• IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
  ανά: Hardman, CS, κ.ά.
  Έκδοση: (2021)